Sept 29 (Reuters) - Caraco Pharmaceutical Laboratories Ltd:
* Enters into consent decree with FDA providing path to resume manufacturing
operations
* Decree provides measures, when satisfied will permit resuming manufacturing,
distributing from Detroit area facilities
* Cessation of manufacturing operations will continue until co gets written
notification from independent experts, FDA
* Nothing in decree prohibits Caraco from distributing FDA approved drug
products that are manufactured by third parties
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Enters into consent decree with FDA providing path to resume manufacturing
operations
* Decree provides measures, when satisfied will permit resuming manufacturing,
distributing from Detroit area facilities
* Cessation of manufacturing operations will continue until co gets written
notification from independent experts, FDA
* Nothing in decree prohibits Caraco from distributing FDA approved drug
products that are manufactured by third parties
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2009 AFX News
